Aromatt 1 (Anastrozole Tablets 1mg)

USDailyMed:Anastrozole AU:C L02BG03(WHO) AU:S4(Prescription only)CA:℞-onlyUK:POM(Prescription only)US:℞-only 2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]bis(2-methylpropanenitrile) 120511-73-1Y 2187 5137 DB01217Y 2102Y 2Z07MYW1AZ D00960Y CHEBI:2704Y ChEMBL1399Y DTXSID9022607 Interactive image N#CC(C)(C)c1cc(Cn2cncn2)cc(c1)C(C)(C)C#N InChI=1S/C17H19N5/c1-16(2,9-18)14-5-13(8-22-12-20-11-21-22)6-15(7-14)17(3,4)10-19/h5-7,11-12H,8H2,1-4H3YKey:YBBLVLTVTVSKRW-UHFFFAOYSA-NY Ana‍​‍‍‍​‍‍‍‍‍‍‍‍​‍strozole, sold under the brand nameArimidexamong others, is anantiestrogenicmedication used in addition to other treatments forbreast cancer.Specifically it is used forhormone receptor-positivebreast cancer.It has also been used to prevent breast cancer in those at high risk.It is takenorally. Common side effects of anastrozole includehot flashes,altered mood,joint pain, andnausea.Severe side effects include an increased risk ofheart diseaseandosteoporosis.Use duringpregnancymay harm the fetus.Anastrozole is in thearomatase-inhibitingfamily of medications.It works by blocking theproductionofestrogensin the body, and hence hasantiestrogeniceffects. Anastrozole was patented in 1987 and was approved for medical use in 1995.It is on theWorld Health Organization's List of Essential Medicines.Anastrozole is available as ageneric medication.In 2023, it was the 194th most commonly prescribed medication in the United States, with more than 2million prescriptions.